Zhejiang Wanfeng Chemical (603172)
Search documents
万丰股份:截至2025年12月19日股东户数为7104户
Zheng Quan Ri Bao Wang· 2025-12-22 11:40
证券日报网讯12月22日,万丰股份(603172)在互动平台回答投资者提问时表示,截至2025年12月19 日,公司的股东户数为7104户。 ...
151只股中线走稳 站上半年线
Zheng Quan Shi Bao Wang· 2025-12-18 06:51
Market Overview - The Shanghai Composite Index closed at 3876.74 points, above the six-month moving average, with a change of 0.17% [1] - The total trading volume of A-shares reached 1,352.099 billion yuan [1] Stocks Breaking the Six-Month Moving Average - A total of 151 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Xingchen Technology (21.97%) - Lude Medical (14.72%) - Suli Co., Ltd. (7.17%) [1] Stocks with Smaller Deviation Rates - Stocks with smaller deviation rates that have just crossed the six-month moving average include: - Huailong Co., Ltd. - Shihong Zhaoye - China Construction Bank [1] Detailed Stock Performance - The following stocks showed notable performance: - Xingchen Technology: +30.00% with a turnover rate of 37.59% and a latest price of 26.48 yuan [1] - Lude Medical: +18.92% with a turnover rate of 37.56% and a latest price of 12.07 yuan [1] - Suli Co., Ltd.: +9.99% with a turnover rate of 7.67% and a latest price of 20.36 yuan [1]
万丰股份股价涨5.16%,广发基金旗下1只基金位居十大流通股东,持有57.79万股浮盈赚取51.43万元
Xin Lang Cai Jing· 2025-12-18 02:54
Group 1 - The core point of the article highlights that WanFeng Co., Ltd. experienced a stock price increase of 5.16%, reaching 18.15 yuan per share, with a total market capitalization of 2.421 billion yuan as of the report date [1] - WanFeng Co., Ltd. is located in Shaoxing, Zhejiang Province, and was established on November 4, 2003. The company was listed on May 10, 2023, and its main business involves the research, production, and sales of disperse dyes and their filter cakes [1] - The main revenue composition of WanFeng Co., Ltd. is 99.39% from disperse dyes and raw dyes, with other income contributing 0.61% [1] Group 2 - From the perspective of the top ten circulating shareholders, Guangfa Fund has a fund that entered the top ten shareholders of WanFeng Co., Ltd. The Guangfa Growth Enterprise Index Enhanced A fund holds 577,900 shares, accounting for 1.15% of the circulating shares [2] - The Guangfa Growth Enterprise Index Enhanced A fund was newly included in the top ten circulating shareholders in the third quarter, with an estimated floating profit of approximately 514,300 yuan as of the report date [2] - The fund manager of Guangfa Growth Enterprise Index Enhanced A is Sun Di, who has been in the position for 8 years and 7 days, with a total fund asset scale of 3.438 billion yuan and a best fund return of 234.15% during his tenure [2]
【公告汇总】12月14日上市公司股份减持一览





Xin Lang Cai Jing· 2025-12-15 01:21
12月14日,截至20时,上市公司发布的股份减持公告汇总如下: 晨丰科技(603685)股东杭州宏沃计划在2026年1月7日至4月6日期间,通过集中竞价和大宗交易方式合 计减持不超过752万股,约占公司总股本的3%。 新雷能(300593)董事、副总经理刘志宇因资金需求,计划自2026年1月7日至2026年4月6日期间通过集 中竞价和大宗交易方式减持不超过40万股公司股份,占剔除回购专用账户后的总股本的0.07%。 凯普生物(300639)职工代表董事谢龙旭因个人资金需求,计划在2026年1月7日至2026年4月6日期间, 通过集中竞价方式减持不超过9.39万股公司股份,约占公司总股本的0.0150%。 百诚医药(301096)股东富诚海富资管—杭州银行—富诚海富通百诚医药员工参与创业板战略配售资管 计划,计划在未来三个月内通过大宗交易或集中竞价方式减持不超过55万股,约占公司总股本的 0.5077%。 万丰股份(603172)股东舟山瑞好通过大宗交易方式减持公司股份233万股,占公司总股本的1.75%。 圣诺生物(688117)股东川发投资通过集中竞价及大宗交易方式累计减持公司股份403万股,占公司总 股本 ...
万丰股份:舟山瑞好减持1.75%股份计划完成
Zheng Quan Ri Bao Wang· 2025-12-14 14:10
证券日报网讯12月14日晚间,万丰股份(603172)发布公告称,舟山瑞好已于2025年12月12日通过大宗 交易减持2,332,400股,占公司总股本1.75%,减持计划实施完毕。 ...
万丰股份:舟山瑞好已减持公司股份约233万股,减持计划实施完毕
Mei Ri Jing Ji Xin Wen· 2025-12-14 07:57
Group 1 - Wan Feng Co., Ltd. announced that Zhoushan Ruihao has reduced its shareholding by approximately 2.33 million shares, accounting for 1.75% of the company's total share capital, and the reduction plan has been completed [1] - For the year 2024, the revenue composition of Wan Feng Co., Ltd. is as follows: dye manufacturing accounts for 99.29%, while other businesses account for 0.71% [1] - The current market capitalization of Wan Feng Co., Ltd. is 2.3 billion yuan [2]
万丰股份(603172) - 浙江万丰化工股份有限公司特定股东减持股份结果公告
2025-12-14 07:45
证券代码:603172 证券简称:万丰股份 公告编号:2025-040 浙江万丰化工股份有限公司 | 持股比例 | 1.75% | | | --- | --- | --- | | 当前持股股份来源 | IPO | 前取得:2,332,400股 | 特定股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 特定股东的基本情况 本次减持计划实施前,舟山瑞好股权投资有限公司(以下简称"舟山瑞好") 持有浙江万丰化工股份有限公司(以下简称"公司")无限售条件流通股 2,332,400 股,占公司总股本的 1.75%,属于公司特定股东。上述股份来源 为公司首次公开发行股票并上市前已有的股份。 减持计划的实施结果情况 2025 年 11 月 21 日,公司披露《浙江万丰化工股份有限公司关于特定股东 减持股份计划公告》(公告编号:2025-039):舟山瑞好计划以大宗交易方 式减持公司股份不超过 2,332,400 股,即不超过公司总股本的 1.75%;自 减持计划公告之日起十五个交易日后的 90 ...
万丰股份:截至2025年12月10日股东户数为7153户
Zheng Quan Ri Bao Wang· 2025-12-11 13:42
证券日报网讯12月11日,万丰股份(603172)在互动平台回答投资者提问时表示,截至2025年12月10 日,公司的股东户数为7153户。 ...
万丰股份:截至2025年11月28日股东户数为7297户
Zheng Quan Ri Bao Wang· 2025-12-04 11:41
证券日报网讯12月4日,万丰股份(603172)在互动平台回答投资者提问时表示,截至2025年11月28 日,公司的股东户数为7297户。 ...
研报掘金丨华鑫证券:予万丰股份“买入”评级,双擎构建增长新空间
Ge Long Hui A P P· 2025-11-26 05:51
Core Viewpoint - Wanfu Co., Ltd. has shown significant growth in net profit for the first three quarters of 2025, indicating strong performance in the mid-to-high-end dye market [1] Financial Performance - The company achieved a net profit attributable to shareholders of 0.37 billion yuan, representing a year-on-year increase of 89.99% [1] - In Q3, the net profit attributable to shareholders was 0.12 billion yuan, with a year-on-year growth of 86.55%, but a quarter-on-quarter decline of 18.13% [1] Industry Position and Growth Potential - Wanfu Co., Ltd. is a leading enterprise in the mid-to-high-end disperse dye segment, with a significant capacity expansion of 10,000 tons expected to enhance performance elasticity [1] - The company is proactively investing in non-reducing cleaning dyes and high-end PI materials, which are anticipated to become new growth drivers for performance [1] Future Profit Forecast - The projected net profits attributable to shareholders for 2025, 2026, and 2027 are 0.53 billion yuan, 0.72 billion yuan, and 0.81 billion yuan, respectively [1] - The current stock price corresponds to price-to-earnings ratios of 47.0, 34.3, and 30.5 times for the years 2025, 2026, and 2027 [1] Investment Rating - The company has been given a "Buy" investment rating based on its growth prospects and financial performance [1]